Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$234.96 - $292.55 $939 - $1,170
-4 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $885 - $1,043
4 New
4 $1,000
Q1 2019

Apr 11, 2019

SELL
$163.73 - $194.7 $3,765 - $4,478
-23 Closed
0 $0
Q1 2018

Apr 19, 2018

BUY
$151.6 - $177.13 $3,486 - $4,073
23 New
23 $4,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Cribstone Capital Management, LLC Portfolio

Follow Cribstone Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cribstone Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cribstone Capital Management, LLC with notifications on news.